Trial Profile
A long-term, comparative study to evaluate the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 03 Dec 2015 New trial record